4HL.BE - Vilmorin & Cie

Berlin - Berlin Delayed Price. Currency in EUR
62.80
+0.70 (+1.13%)
As of 08:08AM CEST. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close62.10
Open62.80
Bid62.60 x 0
Ask62.70 x 0
Day's Range62.80 - 62.80
52 Week Range39.05 - 62.90
Volume255
Avg. Volume4
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 4HL.BE

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Vilmorin & Cie's Board of Directors issues a positive reasoned opinion on the proposed Simplified Public Tender Offer initiated by Limagrain Participation

      Unanimous positive reasoned opinion of Vilmorin & Cie's board members, who deem the Offer to be in the best interests of the Company, its Shareholders and its employeesThe Board of Directors recommends that shareholders tender their shares to the Offer The Board of Directors of Vilmorin & Cie ("Vilmorin" or the "Company") met today to give a reasoned opinion, in accordance with applicable regulations, on the proposed simplified public tender offer for the Company's shares (the "Offer") initiated

    • GlobeNewswire

      Sales on March 31, 2023

      Activity: sales for activities intended for professional markets rose sharply, in spite of major operating difficulties Objectives for 2022-2023: Vilmorin & Cie raises its objective for sales growth*; the other objectives for the end of fiscal year remain unchanged*on a like-for-like basis Vilmorin & Cie’s consolidated sales for the third quarter of 2022-2023, closing on March 31, 2023, corresponding to revenue from ordinary activities, stood at 1,401.0 million euros, up 20.9% with current data

    • GlobeNewswire

      Limagrain, the reference Shareholder of Vilmorin & Cie, announces its intention to initiate a simplified public tender offer on Vilmorin & Cie shares

      Offer at €62.60 per share, representing a premium of 45.4% compared to the last closing share price before the announcement of the Offer and of 36.5% compared to the average volume-weighted share price of the last 60 trading days, offering immediate liquidity to ShareholdersDelisting initiative will enable Vilmorin & Cie to adopt a long-term approach in line with its activities as a seed companyFavorable and unanimous reception of the basis of the Offer by Vilmorin & Cie’s Board of DirectorsThe

    • GlobeNewswire

      Press release from Vilmorin & Cie following the announcement by Limagrain of its intention to file a simplified public tender offer

      Offer at €62.60 per share, representing a premium of 45.4% compared to the last closing share price before the announcement of the Offer and of 36.5% compared to the average volume-weighted share price of the last 60 trading days, offering immediate liquidity to ShareholdersDelisting initiative will enable Vilmorin & Cie to adopt a long-term approach in line with its activities as a seed company Favorable and unanimous reception of the basis of the Offer by Vilmorin & Cie’s Board of Directors Th

    • GlobeNewswire

      Sales and results for the first semester 2022-2023

      Sales for the first semester: confirmation of the dynamic growth in Europe and in South America for Field Seeds, with a market that remains lackluster for Vegetable Seeds Results for the first semester: improvement of the operating income and the net income News: Update on the situation in TurkeyUpdate on the situation in Ukraine and in Russia Objectives for 2022-2023: Vilmorin & Cie partially revises its objectives for the fiscal year Vilmorin & Cie's business is characterized by significant st

    • GlobeNewswire

      Combined Annual General Meeting 2022

      COMBINED ANNUAL GENERAL MEETING 2022 Approval of the financial statements for 2021-2022, showing total net income of 95.4 million eurosA net dividend of 1.60 euros per share, constant in nominal value compared to the previous fiscal yearConfirmation of the objectives for 2022-2023 The Combined Annual General Meeting of Vilmorin & Cie's Shareholders was held on Friday December 9, 2022 in Cournon-d’Auvergne (France), under the chairmanship of Sébastien VIDAL, Chairman and CEO. The Shareholders the

    • GlobeNewswire

      Sales on September 30, 2022

      Activity: driven by Field Seeds, sales for activities intended for professional markets rose sharply Objectives for 2022-2023: Vilmorin & Cie confirms its objectives for the fiscal year News: Filing of the Universal Registration Document for 2021-2022Preparation of the Combined Annual General Meeting (Ordinary and Extraordinary) of December 9, 2022 Vilmorin & Cie’s consolidated sales for the first quarter of 2022-2023, closing on September 30, 2022, corresponding to revenue from ordinary activit

    • GlobeNewswire

      Results for the fiscal year on June 30, 2022

      Vilmorin & Cie once again demonstrates the resilience of its model by achieving solid commercial and financial performances Proposal of a dividend of 1.60 euros per share at the upcoming Annual General Meeting of Shareholders, in Auvergne News: a new research partnership concerning pulses in Canada Objectives for 2022-2023: business growth of between 6% and 8%* and a current operating margin rate of at least 8% *On a like-for-like basis. Financial statements for fiscal year 2021-2022:Vilmorin &

    • GlobeNewswire

      Sale for the fiscal year on June 30, 2022

      Business: Vilmorin & Cie manages to exceed its consolidated sales growth objective for the year, in spite of a general destabilized context News: Update on the situation in Ukraine and in RussiaVilmorin & Cie announces the signing of a new research partnership in Canada concerning pulsesAnthony CARVALHO, appointed Vilmorin & Cie's Chief Financial Officer as of September 14, 2022 Outlook for the end of 2021-2022 Closing on June 30, 2022, Vilmorin & Cie's sales for the fourth quarter, correspondin

    • GlobeNewswire

      Olivier Falut leaves his position as Chief Financial Officer of Vilmorin & Cie

      Vilmorin & Cie announces the departure today of Olivier Falut, Chief Financial Officer, by mutual agreement with Franck Berger, Delegate Chief Executive Officer. Olivier Falut had joined the Company in September 2020. Pending the appointment of his replacement, Franck Berger will act as interim Chief Financial Officer. Coming disclosures and events For any further information Monday August 1, 2022(1)Disclosure of sales for fiscal year 2021-2022 Wednesday October 12, 2022(1)Disclosure of results